Intraindividual Variability as a Marker of Neurological Dysfunction: A Comparison of Alzheimer's Disease and Parkinson's Disease

By Burton Catherine   Strauss Esther   Hultsch David   Moll Alex   Hunter Michael  

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 28, Iss. 1, 2006-01 ,pp. : 67-83

Routledge Ltd

Access to resources Recommend Favorite

A novel screen for nuclear mitochondrial gene associations with Parkinson’s disease

By Mellick G. D.   Silburn P. A.   Prince J. A.   Brookes A. J.  

Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. : 191-199

Springer Publishing Company

Access to resources Recommend Favorite

A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility

By Gray J.  

Brain, Vol. 125, Iss. 6, 2002-06 ,pp. : 1337-1347

Oxford University Press

Access to resources Recommend Favorite

Rapid onset of efficacy of rasagiline in early Parkinson’s disease

By Zambito Marsala Sandro   Vitaliani Roberta   Volpe Daniele   Capozzoli Francesca   Baroni Luciana   Belgrado Enrico   Borsato Carlo   Gioulis Manuela   Marchini Corrado   Antonini Angelo  

Neurological Sciences, Vol. 34, Iss. 11, 2013-11 ,pp. : 2007-2013

Springer Publishing Company

Access to resources Recommend Favorite

Screening for cognitive impairment in Parkinson’s disease – which marker relates to disease severity?

By Riepe M. W.   Kassubek J.   Tracik F.   Ebersbach G.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1463-1468

Springer Publishing Company

Access to resources Recommend Favorite